SCHEMBL23833752

SCHEMBL23833752

COc1ccc(NC(=O)c2cnc(-c3ccccc3)o2)cc1S(=O)(=O)Nc1cccc(C#N)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.51
ALPL P05186 4/20 0.48
ALDH1A1 P00352 5/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPT P10636 4/20 0.47
KDM4E B2RXH2 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
TNF P01375 1/20 0.47
NOD2 Q9HC29 1/20 0.47
NOD1 Q9Y239 1/20 0.47
LMNA P02545 3/20 0.45
PTPN2 P17706 2/20 0.45
PTPN1 P18031 2/20 0.45
PTPN5 P54829 2/20 0.45
CPT1A P50416 1/20 0.44
CPT1B Q92523 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
GAA P10253 2/20 0.43
ALOX12 P18054 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30199378 1.00 TP53 (0.51) TP53ALPLALDH1A1MEN1KMT2A
SCHEMBL23846471 0.85 TP53 (0.51) TP53ALPLALDH1A1MEN1KMT2A
SCHEMBL23846671 0.85 MAPT (0.60) ALPLALDH1A1MEN1KMT2AMAPT
SCHEMBL25757359 0.85 KMT2A (0.49) ALPLALDH1A1MEN1KMT2AMAPT
SCHEMBL23846612 0.84 MAPT (0.51) ALPLALDH1A1MEN1KMT2AMAPT
SCHEMBL23846613 0.83 MEN1 (0.51) TP53ALPLALDH1A1MEN1KMT2A
SCHEMBL23846623 0.75 SCN10A (0.51) ALPLALDH1A1MEN1KMT2AMAPT
SCHEMBL23833464 0.73 PIK3C3 (0.46) ALPLMAPTPTPN2PTPN1PTPN5
SCHEMBL25757314 0.73 PTPN2 (0.57) ALPLALDH1A1MEN1KMT2AMAPT
SCHEMBL23846617 0.72 MAPT (0.56) TP53ALPLALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
EP-4121029-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF Amathus Therapeutics, Inc. (US) 2023-01-25 EP disclosed
WO-2021188880-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 TP53 13/4885ALPL 3721/4885ALDH1A1 2569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.